4.8 Letter

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications

Journal

NEW ENGLAND JOURNAL OF MEDICINE
Volume 384, Issue 19, Pages 1866-1868

Publisher

MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2100362

Keywords

-

Ask authors/readers for more resources

The emergence of SARS-CoV-2 variants, including B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351), and P.1 (B.1.1.28.1), has raised concerns about worsening Covid-19 and potential escape from vaccine-induced immunity.
The Challenge of SARS-CoV-2 Variants The emergence of the SARS-CoV-2 variants B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351) and P.1 (B.1.1.28.1) has aroused many concerns, including worsening Covid-19 and escape from vaccine-induced immunity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available